Patents/Assignees

ACCUTAR BIOTECHNOLOGY

1 patent in portfolio

US11642342utility2023
Combinations of Estrogen Receptor Degraders and Cyclin-dependent Kinase Inhibitors for Treating Cancer
0 cites